Stryker is an American multinational medical company that is recognized for Product Launches and Research and Development in the 2022 Medical Device Network Excellence Awards.

During the research period the company partnered with Indian healthcare company Hunjan hospital to launch the Mako Robotic Arm-Assisted Surgery system. The system can create a 3D model of the damaged joint, give a personalized digital surgical plan to match each individual patient and suggest a modified surgery plan in case of an emergency.

Stryker also released its new Citrelock Tendon Fixation Device System, which enables safe tendon fixation while simultaneously preventing bulk degradation and chronic inflammation. The system uses a new tendon thread material called Citregen, which is composed of citrate, calcium and phosphate molecules.

Again in the realm of invasive procedure devices, the FDA approved Stryker’s biodegradable subacromial balloon spacer. The device is called InSpace and is meant to treat torn rotator cuff tendons. The implant can restore the tendons in the subacromial space without the use of sutures or fixation devices.

Company Profile

Stryker is a medical technology company which is engaged in manufacturing of an array of orthopedic, medical and surgical, and neurotechnology and spine products and allied services. 

Its major products include orthopedic implants; surgical equipment and surgical navigation systems; patient handling, emergency medical equipment and intensive care disposable products; endoscopic and communications systems. 

It also offers neurosurgical equipment, neurovascular and spinal devices; and medical devices for use in a variety of conditions. Stryker offers products to doctors, hospitals and other healthcare facilities. 

The company sells its products through subsidiaries, branches, third-party dealers and distributors in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Stryker is headquartered in Kalamazoo, Michigan, the US.